1. Home
  2. DWSN vs IFRX Comparison

DWSN vs IFRX Comparison

Compare DWSN & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

HOLD

Current Price

$2.12

Market Cap

58.4M

Sector

Energy

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$0.83

Market Cap

67.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DWSN
IFRX
Founded
1952
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.4M
67.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
DWSN
IFRX
Price
$2.12
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.50
AVG Volume (30 Days)
65.5K
609.3K
Earning Date
11-12-2025
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$64,312,000.00
$73,729.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,054.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$0.71
52 Week High
$5.54
$2.77

Technical Indicators

Market Signals
Indicator
DWSN
IFRX
Relative Strength Index (RSI) 54.34 36.10
Support Level $2.00 $0.88
Resistance Level $2.34 $1.01
Average True Range (ATR) 0.18 0.09
MACD -0.00 -0.01
Stochastic Oscillator 50.31 8.87

Price Performance

Historical Comparison
DWSN
IFRX

About DWSN Dawson Geophysical Company

Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: